These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki H, Ikawa S. Cancer; 2000 Feb 01; 88(3):529-37. PubMed ID: 10649243 [Abstract] [Full Text] [Related]
7. Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Scand J Gastroenterol; 2004 Feb 01; 39(2):168-73. PubMed ID: 15000280 [Abstract] [Full Text] [Related]
12. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. Liang HL, Yang CF, Pan HB, Lai KH, Cheng JS, Lo GH, Chen CK, Lai PH. Radiology; 2000 Mar 08; 214(3):769-74. PubMed ID: 10715044 [Abstract] [Full Text] [Related]
13. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma. Chen RC, Liao LY, Wang CS, Chen WT, Wang CK, Li YH, Tu HY, Chen PH. AJR Am J Roentgenol; 2003 Dec 08; 181(6):1647-52. PubMed ID: 14627590 [Abstract] [Full Text] [Related]
15. Echo-guided percutaneous ethanol injection in small hepatocellular carcinoma: personal experience. Solmi L, Muratori R, Bertoni F, Gandolfi L. Hepatogastroenterology; 1993 Oct 08; 40(5):505-8. PubMed ID: 8270245 [Abstract] [Full Text] [Related]
16. Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma. Kurokohchi K, Masaki T, Miyauchi Y, Funaki T, Yoneyama H, Miyoshi H, Yoshida S, Himoto T, Morishita A, Uchida N, Watanabe S, Kuriyama S. Int J Oncol; 2004 Feb 08; 24(2):381-7. PubMed ID: 14719115 [Abstract] [Full Text] [Related]
17. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study. Tsai WL, Cheng JS, Lai KH, Lin CP, Lo GH, Hsu PI, Yu HC, Lin CK, Chan HH, Chen WC, Chen TA, Li WL, Liang HL. Aliment Pharmacol Ther; 2008 Aug 01; 28(3):304-11. PubMed ID: 19086330 [Abstract] [Full Text] [Related]
18. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Orlando A, D'Antoni A, Cammà C, Albanese M, Livraghi T, Torzilli G, Virdone R, Sciarrino E, Simonetti RG, Maringhini A, Pagliaro L, Cottone M. Am J Gastroenterol; 2000 Oct 01; 95(10):2921-7. PubMed ID: 11051369 [Abstract] [Full Text] [Related]
20. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M. J Hepatol; 2000 Feb 01; 32(2):269-78. PubMed ID: 10707867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]